Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
2(25%)
Results Posted
67%(2 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
8
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
N/ANon-phased studies
8(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
Recruiting1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
60.0%
Most Advanced
N/A

Trials by Phase

N/A8 (100.0%)

Trials by Status

recruiting113%
completed338%
active_not_recruiting113%
unknown113%
terminated225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8